Hôpital Général de Référence St Luc, Kisantu, DR Congo Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Alternative names

Hôpital Général de Référence St Luc, Kisantu, DR Congo

Active Ingredients

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 3)

Malaria (Phase 3)

Malaria, Falciparum (Phase 3)

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0